主页文献库搜索
POU2F3 in Small Cell Lung Cancer (SCLC): Diagnostic Utility in Neuroendocrine...

Chen(X),Zou(F),Xu(H),Zhang(Z),Wang(J),Li(Y... Lab Invest 2026-06-00

...SMARCA4-deficient thoracic undifferentiated tumor, atypical carcinoid, and adenoid cystic carcinoma. Notably, the highly...

Surgical education video: Laparoscopic Hyperthermic Intraperitoneal Chemother...

Huizar(GD),Mokshagundam(S),Grotz(TE),Kumar(A) Gynecol Oncol Rep 2026-04-00

...SMARCA4 mutation. The patient completed four cycles of adjuvant vinblastine, cisplatin, cyclophosphamide, bleomycin, dox...

Case Report: SMARCA4-deficient non-small cell lung cancer - effective local c...

Luo(J),Lin(S),Wang(M),Zeng(Y),Tang(W) Front Oncol None

SMARCA4-deficient non-small cell lung cancer (SMARCA4-dNSCLC) represents a distinct, highly aggressive molecular subtype...

The computational analysis of tumor cell sensitivity to supertarget deletion.

Chetverina(DA),Kozelchuk(NY),Lomaev(DV),Sh... Vavilovskii Zhurnal Genet S... 2026-03-00

...SMARCA4). The genetic changes included GOF mutations (KRAS, BRAF genes, etc.), LOF mutations (STAG1, SMARCA2 genes, etc....

Congenital hypothyroidism with preserved fifth digits in SMARCA4-related Coff...

Shah(SJ),Ravi(U),Dattani(AV),Mariswamy Aru... AME Case Rep None

...SMARCA4, are known to cause CSS with variable phenotype expression. The expanded use of genotype-first methods has contr...

Neuro-immune-related gene signatures define molecular subtypes and prognostic...

Nie(Q),Jiang(M),Wan(S),Xi(M),Hua(W),Jiang(... PeerJ None

...SMARCA4, while the NAS-low state showed immune-regulatory features. Functional assays confirmed that SERPINE2 knockdown ...

Restoration of RBM22 overcomes the transcriptional and epigenetic barriers of...

Duan(X),Tan(Y),Zhang(Y),Wang(B),Zhang(S),L... Nat Commun 2026-03-09

...SMARCA4 to enhance transcriptional accessibility. Furthermore, RBM22 is essential for the gene-specific recruitment of R...

SMARCA4-deficient carcinoma of the head and neck region: report of 8 new sino...

Farkas(M),Agaimy(A),Švajdler(M),Hauer(L),M... Virchows Arch 2026-05-00

...SMARCA4-deficient cancers, including SMARCA4-deficient sinonasal carcinomas, and most sinonasal teratocarcinosarcomas. T...

SMARCA4/2 loss reduces BCL-xL expression and confers a druggable MCL1 depende...

Jiang(J),Zhu(X),Fu(Z),Liao(M),Arabzadeh(A)... NPJ Precis Oncol 2026-03-10

...SMARCA4/2-deficient SCCOHT and NSCLC cells but not in SMARCA4/2-proficient controls. Mechanistically, SMARCA4/2 directly...

Analysis of clinical and genomic features in a Chinese cohort with NRG1 varia...

Zhang(M),Feng(Y),Du(X),Qu(C),Meng(M),Ye(M)... Transl Lung Cancer Res 2026-02-28

...SMARCA4, KMT2A, and ARID1A. No hotspot mutation sites in NRG1 were found. The overall objective response rate of all NRG...

上一页 1 2 3 4 5 6 下一页 2 / 共 46

联系地址

山东省济南市章丘区文博路2号

齐鲁师范学院 genelibs生信实验室

山东省济南市高新区舜华路750号

大学科技园北区F座4单元2楼

电话: 0531-88819269

微信公众号

关注微信订阅号,实时查看信息,关注医学生物学动态。


商务邮箱

E-mail: product@genelibs.com